Rod-type medicinal drug dosing apparatus

FIELD: medicine, in particular, rectal dosed transportation of medicinal drugs into straight intestine.

SUBSTANCE: dosing apparatus has casing adapted for introduction into hollow organ and made in the form of continuous rod. Cavities for treating ointments on cylindrical outer part of rod are formed as slots. Rear end of rod has reduced diameter in comparison with maximal diameter of rod. Guiding pipe loosely put onto said end has outer diameter exceeding maximal diameter of casing. Figures are applied in equally spaced relation along length of pipe. Flexible cord with round restricting member is fixed at rear end of rod.

EFFECT: increased efficiency in transporting of high-density medicinal drugs, in particular, treating ointments, immediately to point of application.

2 cl, 2 dwg

 

The invention relates to medicine, in particular to a device intended for the introduction of drugs into the hollow body, and is used, for example, for rectal dosage of drug delivery into the rectum or other place of human body.

Currently known rectal, vaginal and other candles intended for controlled drug delivery in the hollow body ("concise medical encyclopedia" volume 2, page 57, article "Dosage forms", ed. "Soviet encyclopedia", 1989). These candles have a hard copy of the wax to become involved in drugs. The candle is inserted into the rectum with your finger and after some time melts the inside of the intestine, and the drug is absorbed, causing the necessary therapeutic effect. The lack of spark is that when entering candles finger cannot accurately determine its location inside the rectum. All this reduces the effectiveness of the treatment. In addition, the wax has a high cost, therefore, the use of disposable candles uneconomical. Known medication in the human body in the form of ointments from the tubes using a cannula according to the patent of Russian Federation (RU # 2143288 C1, published 27.12.99). The main disadvantage is the inaccuracy of drug delivery, coming to a sick body. In addition, the tubes and the tubes after which procedure remains a lot of untapped ointments.

As the prototype is considered a device for the dosed introduction of medicinal ointments in the anus and rectum to the patent of Russian Federation (RU # 22204422 C1, published 20.05.2003)containing a sleeve with a cavity for ointments and rod-piston to eject. The rear end of the sleeve is made in the form of a gripper with spring petals, gripping the piston rod. On the surface of this piston are risks and figures for fixing the position relative to the anus. On the front end of the sleeve has an overflow hole, which connects the cavity of the liner with the atmosphere. The main drawbacks are the inaccuracy of drug delivery to the patient body and wasteful consumption of large amounts of ointment, as ointments are distributed throughout the cavity of the rectum, and not about the place of treatment. This is particularly unacceptable when using potent drugs, such as bee venom. The disadvantage is the impossibility of quick simultaneous dosing of multiple drugs within one procedure. In addition, in the cavity of the liner after the procedure, there is a lot of unused ointments.

The invention solves the problem of accurate, metered and cost-effective delivery of medicinal ointments in any area of the hollow body device having a simple construction. Possible odnovremennaya dosage multiple combinations of drugs and shipping them to the desired location within one procedure. All this greatly increases the effectiveness of the treatment.

To achieve this, the technical result in the present invention the sleeve is introduced into the hollow body, made in the form of a solid rod, which with the outer cylindrical part manufactured cavity for medicinal ointments in the form of recesses. The rear end of the rod has a reduced diameter compared with the maximum diameter of the rod. To this end equipped with free planting guide tube, the outer diameter of which does not exceed the maximum diameter of the sleeve. The length of the tube uniformly applied numerals, and the rear end of the rod attached flexible cord with round stopper.

The limiter can be made on the rear end of the rod after the cylindrical part with a reduced diameter in the form of a hard limiter, the maximum diameter of which exceeds the maximum stem diameter of not less than 2 times.

The rod can be made of ebony.

Distinctive features of the proposed core medicine dispenser (NLL) from the above known of the closest device for the dosed introduction of medicinal ointments in the anus and rectum, is the fact that the sleeve is made in the form of a continuous rod, and with the outer cylindrical part (and not inside it, as in the prototype) made cavity DL is a therapeutic ointments in the form of recesses. The distinguishing feature is that the rear end of the rod has a reduced diameter compared with the maximum diameter of the rod. To this end equipped with free planting guide tube, the outer diameter of which does not exceed the maximum diameter of the sleeve. The length of the tube uniformly applied numerals, and the rear end of the rod attached flexible cord with round stopper.

Due to the presence of these symptoms rod with healing ointments grooves can be precisely and painless to enter the hollow body. The rear end of the rod has a reduced diameter compared with the maximum diameter of the rod, which allows this end to wear with a loose fit cylindrical guide tube. After the introduction tube is freely taken out, leaving the stem with medicated ointments inside the hollow body for a long time, during which the ointment is diffused to the sore spot, being with him in the immediate vicinity. Mounted on the rear end of the rod flexible cord with round limiter prevents the cord completely to get inside. The limiter serves for removal of the rod from the body after the procedure. Figures applied evenly along the length of the tube, serve to accurately fix the position of the rod in the hollow body.

The hard limiter can be performed on the rear end of the of terina with maximum diameter exceeding the maximum stem diameter of not less than 2 times. This size does not allow the rod to completely go inside of a hollow organ. The hard limiter is also the position lock rod relative to the location of treatment and capture to extract the NLL from the body. With this design the NLL is not necessary to use a tube for introducing him to the hollow body. The disadvantage is that the position of the guide is fixed relative to the rod, and therefore in each case the individual production NLL certain length for each man or illness, i.e. the NLL is becoming less universal. Remove from the rectum of a rod is for this hard limiter. In addition, with prolonged (more than 4 hours) finding such a rod in the rectum squeezing the muscles of the anus can relax, which is an undesirable factor in the treatment of diseases of the rectum.

The rod can be made of ebonite. This ebony stud gives additional therapeutic effect, as ebonite has healing properties (see Rukin PPM, Asianow N.A., Ageeva SF the Healing properties of stones and metals, publishing the FIELD of RUSSIA", Moscow, 1999).

The proposed SDL is illustrated in the drawings, figure 1, 2. General view of the NLL shown in figure 1. The NLL has a cylindrical CTE is Zhen 1, the front end 2 of which is spherical, and the rear end 3 has a reduced diameter compared with the maximum diameter of the rod. At the end of the attached flexible cord 4 with the stopper 5. The rod is made depressions in the form of wavy annular grooves 6. Here is guide tube 7 is mounted with a loose fit on the rear end of the rod and which is applied to marking figures 8.

Figure 2 shows a variant of the NLL with hard limiter 9 at the rear end of the rod. The functioning of the NLL can be described in its application for the treatment of prostatitis. Before using the grooves 6 are filled medicinal ointments. Then on the rear end of the rod 3 with a loose fit fitted guide tube 7. The rod with the tube inserted in the rectum to figures marking the insertion depth corresponding to the distance from the anus to the prostate (prescribed by the attending physician). This allows, in the absence of a physician (clinic, home) always accurately set the rod in the right place rectum relative to the prostate. The tube is removed, the stopper 5 is located outside the body. Terminal 1 remains in the rectum at the time prescribed by the attending physician (approximately 4-8 hours, possibly overnight). Drugs from drillings 6 diffuse through the walls of the rectum to the prostate, the cent is asasa next, and treat her. After the procedure, and complete diffusion of the drug core 1 for the limiter and flexible cord is removed from the rectum.

The proposed SDL developed drawings made samples, the last stage of medical research and preparation of serial production.

The use of the NLL has shown in practice to clinical effectiveness, ease of use and efficiency in the prevention and treatment of fractures, cysts and polyps of the rectum, and hemorrhoids. Special efficiency NLL shows in the treatment of prostatitis, as its introduction into the rectum provides the closest contact with the prostate. Repeated use of the rod with the medicinal ointments provides a significant economic effect compared to using disposable candles of expensive wax.

1. Core medicine dispenser containing a sleeve with a cavity for medicinal ointments, wherein the sleeve is made in the form of a rod, on which the outer cylindrical part manufactured cavity for medicinal ointments in the form of recesses, the diameter of the rear end of the rod is smaller than the maximum diameter of the rod, at the end put on free planting guide tube, the outer diameter of which does not exceed the maximum diameter of the sleeve, the length of the tube uniformly applied t is fry to indicate an insertion depth, and at the rear end of the rod attached flexible cord with round stopper.

2. Rod dispenser according to claim 1, characterized in that the rod is made of ebony.



 

Same patents:

FIELD: medical procedures.

SUBSTANCE: patients preliminarily undergo endoscopic papillo-sphincterotomy, whereupon stone in common bile duct is dissolved and removed by way of supplying stone-dissolving therapeutic mixture, in particular 1:1 solution of diethyl ether in olive oil, directly to bile stone. Therapeutic mixture creates, in the lumen of bile duct, hydrostatic pressure 200 mm water head. More specifically, 120 ml of therapeutic mixture is supplied during one day at a rate of 10 drops/min, while performing 5 to 16 daily sessions of stone-dissolving therapy.

EFFECT: increased efficiency in removal of sparingly soluble stones in common bile duct.

2 ex

FIELD: medicine, medicinal parasitology.

SUBSTANCE: the present innovation deals with affecting the helminthes with curative mixture made out of eucalyptus leaf at addition of eucalyptus essential oil. Curative mixture at the quantity of 1 l at 40-42 C should be daily introduced into patient's rectum with enemas for 5-7 d at intestinal keeping for 15-20 min. Before introducing the curative mixture it is necessary to apply purifying enema. The method suggested provides removal of different types of helminthes at excluding toxic action upon human body.

EFFECT: higher efficiency of helminthic removal.

3 ex

FIELD: medicine.

SUBSTANCE: method involves forming urinary bladder from retained walls after having done subtotal resection. 20-40 ml of physiologic saline and 10 ml dioxidine is introduced at the twenty first day after surgical operation for 2-3 h 3-4 times a day to cause marked vesical tenesmus. Spasmex is applied at a dose of 20 mg 3 times a day during 12 weeks.

EFFECT: enhanced effectiveness of treatment.

FIELD: medicine.

SUBSTANCE: method involves introducing cauterizing necrotizing composition like paste containing silver nitrate and dextrane into uterine cavity. Paste contact to target tissue is supported during time enough for reaching chemical necrosis. Then cauterizing composition is brought in contact with deactivating agent like aqueous solution of sodium chloride and removed from the uterine cavity later on. It is proposed to protect non-target tissue by supplying protection agent to it and carrying out previously described steps.

EFFECT: enhanced effectiveness of cauterization controlled in time and action intensity degree; avoided other tissue injuries.

30 cl, 8 dwg

FIELD: medicine, surgery, coloproctology.

SUBSTANCE: one should introduce gelatin-based colloids: gelatinol or gelofusin and crystalloids at 1:1 ratio at total volume of 40-50 ml/kg patient's body weight daily; additionally, since the 2nd to the 7th d after operation it is necessary to conduct enteral nutrition in the form of hypercaloric mixtures by increasing their volume at higher rate of injection starting from 25 ml/h/kg body weight on the 2nd and 3d d up to 100 ml/h on the 6th-7th d. The present innovation enables to improve nutrition of intestinal endothelium, decrease pathogenic and conditionally pathogenic microflora, prevents appearance of postoperational intestinal paresis and restores its function in more shortened terms.

EFFECT: higher efficiency.

1 ex, 3 tbl

The invention relates to medicine, obstetrics and anesthesia, and can be used for delivery of women with preeclampsia in the second half of pregnancy

The invention relates to medicine, in particular to vascular surgery

The invention relates to a device for slowing the passage through the pylorus introduced oral dosage forms

The invention relates to medical instruments and can be used, for example, removing an ornate krovosnabjaemah of brain tumors using direct interstitial introduction of an embolizing substance

FIELD: medicine, surgery, coloproctology.

SUBSTANCE: one should introduce gelatin-based colloids: gelatinol or gelofusin and crystalloids at 1:1 ratio at total volume of 40-50 ml/kg patient's body weight daily; additionally, since the 2nd to the 7th d after operation it is necessary to conduct enteral nutrition in the form of hypercaloric mixtures by increasing their volume at higher rate of injection starting from 25 ml/h/kg body weight on the 2nd and 3d d up to 100 ml/h on the 6th-7th d. The present innovation enables to improve nutrition of intestinal endothelium, decrease pathogenic and conditionally pathogenic microflora, prevents appearance of postoperational intestinal paresis and restores its function in more shortened terms.

EFFECT: higher efficiency.

1 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: method involves introducing cauterizing necrotizing composition like paste containing silver nitrate and dextrane into uterine cavity. Paste contact to target tissue is supported during time enough for reaching chemical necrosis. Then cauterizing composition is brought in contact with deactivating agent like aqueous solution of sodium chloride and removed from the uterine cavity later on. It is proposed to protect non-target tissue by supplying protection agent to it and carrying out previously described steps.

EFFECT: enhanced effectiveness of cauterization controlled in time and action intensity degree; avoided other tissue injuries.

30 cl, 8 dwg

FIELD: medicine.

SUBSTANCE: method involves forming urinary bladder from retained walls after having done subtotal resection. 20-40 ml of physiologic saline and 10 ml dioxidine is introduced at the twenty first day after surgical operation for 2-3 h 3-4 times a day to cause marked vesical tenesmus. Spasmex is applied at a dose of 20 mg 3 times a day during 12 weeks.

EFFECT: enhanced effectiveness of treatment.

FIELD: medicine, medicinal parasitology.

SUBSTANCE: the present innovation deals with affecting the helminthes with curative mixture made out of eucalyptus leaf at addition of eucalyptus essential oil. Curative mixture at the quantity of 1 l at 40-42 C should be daily introduced into patient's rectum with enemas for 5-7 d at intestinal keeping for 15-20 min. Before introducing the curative mixture it is necessary to apply purifying enema. The method suggested provides removal of different types of helminthes at excluding toxic action upon human body.

EFFECT: higher efficiency of helminthic removal.

3 ex

FIELD: medical procedures.

SUBSTANCE: patients preliminarily undergo endoscopic papillo-sphincterotomy, whereupon stone in common bile duct is dissolved and removed by way of supplying stone-dissolving therapeutic mixture, in particular 1:1 solution of diethyl ether in olive oil, directly to bile stone. Therapeutic mixture creates, in the lumen of bile duct, hydrostatic pressure 200 mm water head. More specifically, 120 ml of therapeutic mixture is supplied during one day at a rate of 10 drops/min, while performing 5 to 16 daily sessions of stone-dissolving therapy.

EFFECT: increased efficiency in removal of sparingly soluble stones in common bile duct.

2 ex

FIELD: medicine, in particular, rectal dosed transportation of medicinal drugs into straight intestine.

SUBSTANCE: dosing apparatus has casing adapted for introduction into hollow organ and made in the form of continuous rod. Cavities for treating ointments on cylindrical outer part of rod are formed as slots. Rear end of rod has reduced diameter in comparison with maximal diameter of rod. Guiding pipe loosely put onto said end has outer diameter exceeding maximal diameter of casing. Figures are applied in equally spaced relation along length of pipe. Flexible cord with round restricting member is fixed at rear end of rod.

EFFECT: increased efficiency in transporting of high-density medicinal drugs, in particular, treating ointments, immediately to point of application.

2 cl, 2 dwg

FIELD: medicine, arthrology.

SUBSTANCE: the present innovation deals with treating arthritis of different etiology. For this purpose one should introduce medicinal preparation into articular cavity and immediately after introduction one should periodically change spatial articular position at the interval of 20-30 min. The present innovation provides efficient and safe treatment of arthritis due to steady distribution of medicinal substance along the whole area of articular surface.

EFFECT: higher efficiency of therapy.

1 cl, 2 ex

FIELD: oncology.

SUBSTANCE: invention provides a chemotherapy method that can be used in treatment of patients with widespread abdominal tumors. When performing laparotomy, sub-peritoneal infiltration with autoblood solution containing chemical agent is effected on zones of tumor infiltrates (supraperitoneal paraaortic tissue) and root of mesentery region.

EFFECT: expanded tumor treatment possibilities.

FIELD: medicine.

SUBSTANCE: method involves beginning disinvagination with mask narcosis by pumping air into large intestine under X-ray control. The invaginate remaining unstretched, the air is discharged from the intestine by massaging abdomen along the large intestine and pressing abdomen flanks. Next to it, air is pumped into the large intestine and invaginate stretching is carried out with an additional coercion by squeezing invaginated head out towards the neck part. No success being achieved, the procedure is repeated with mask narcosis to eight times. The invaginate remaining unstretched, endotracheal narcosis is given to the patient and myorelaxant drug of transitory action is introduced. Air volume introduced into the intestine is increased. The invaginate-stretching procedure is repeated with endotracheal narcosis to five times.

EFFECT: enhanced effectiveness of treatment.

FIELD: medicine.

SUBSTANCE: method involves administering triple injections of medicament mixture composed of Lidase 32 units, Anicaine 4ml, Dexamethazon 4 mg, Alflutop 1 ml, into Hoff fat pad.

EFFECT: reduced pain and knee joint edema manifestations; increased joint range of motions.

5 tbl

Up!